The ReNeu study is for people ages 2 to 17 with a plexiform neurofibroma (PN) associated with Neurofibromatosis type 1 (NF1). The purpose of this study is to determine the effectiveness of the study drug at improving a PN that is causing significant issues in people with NF1.
Advances in NF1 research are made possible by clinical research study participants. If you have questions about study participation, we are here to help.
